176 related articles for article (PubMed ID: 36354709)
41. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065
[TBL] [Abstract][Full Text] [Related]
42. Particle beam radiation therapy for sinonasal malignancies: Single institutional experience at the Shanghai Proton and Heavy Ion Center.
Hu W; Hu J; Huang Q; Gao J; Yang J; Qiu X; Kong L; Lu JJ
Cancer Med; 2020 Nov; 9(21):7914-7924. PubMed ID: 32977357
[TBL] [Abstract][Full Text] [Related]
43. Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study.
Fischer M; Moreno L; Ziegler DS; Marshall LV; Zwaan CM; Irwin MS; Casanova M; Sabado C; Wulff B; Stegert M; Wang L; Hurtado FK; Branle F; Geoerger B; Schulte JH
Lancet Oncol; 2021 Dec; 22(12):1764-1776. PubMed ID: 34780709
[TBL] [Abstract][Full Text] [Related]
44. The role of irradiation in the management of locally recurrent non-metastatic soft tissue sarcoma of extremity/trunkal locations.
Fontanesi J; Mott MP; Lucas DR; Miller PR; Kraut MJ
Sarcoma; 2004; 8(2-3):57-61. PubMed ID: 18521396
[TBL] [Abstract][Full Text] [Related]
45. Tandem High-dose Chemotherapy without Craniospinal Irradiation in Treatment of Non-metastatic Malignant Brain Tumors in Very Young Children.
Ma Y; Lim DH; Cho H; Lee JW; Sung KW; Yoo KH; Koo HH; Shin HJ; Suh YL
J Korean Med Sci; 2020 Dec; 35(48):e405. PubMed ID: 33316857
[TBL] [Abstract][Full Text] [Related]
46. Optimal management of recurrent and metastatic upper tract urothelial carcinoma: Implications of intensity modulated radiation therapy.
Kim MS; Koom WS; Cho JH; Kim SY; Lee IJ
Radiat Oncol; 2022 Mar; 17(1):51. PubMed ID: 35264197
[TBL] [Abstract][Full Text] [Related]
47. Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas.
Verma J; McCutcheon IE; Waguespack SG; Mahajan A
Pituitary; 2014 Dec; 17(6):539-45. PubMed ID: 24272035
[TBL] [Abstract][Full Text] [Related]
48. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
[TBL] [Abstract][Full Text] [Related]
49. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
[TBL] [Abstract][Full Text] [Related]
50. Proton therapy for reirradiation of progressive or recurrent chordoma.
McDonald MW; Linton OR; Shah MV
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1107-14. PubMed ID: 24267972
[TBL] [Abstract][Full Text] [Related]
51. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
Bradfield SM; Douglas JG; Hawkins DS; Sanders JE; Park JR
Cancer; 2004 Mar; 100(6):1268-75. PubMed ID: 15022296
[TBL] [Abstract][Full Text] [Related]
52. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
[TBL] [Abstract][Full Text] [Related]
53. Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas.
Murray FR; Snider JW; Bolsi A; Lomax AJ; Walser M; Kliebsch U; Schneider RA; Weber DC
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1190-1198. PubMed ID: 28939227
[TBL] [Abstract][Full Text] [Related]
54. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
55. Dose-escalation is needed for gross disease in high-risk neuroblastoma.
Casey DL; Kushner BH; Cheung NV; Modak S; LaQuaglia MP; Wolden SL
Pediatr Blood Cancer; 2018 Jul; 65(7):e27009. PubMed ID: 29469198
[TBL] [Abstract][Full Text] [Related]
56. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
[No Abstract] [Full Text] [Related]
57. Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy.
Lautenschlaeger S; Dumke C; Exeli L; Hauswald H; Engenhart-Cabillic R; Eberle F
Strahlenther Onkol; 2023 Nov; 199(11):982-991. PubMed ID: 37428207
[TBL] [Abstract][Full Text] [Related]
58. Radiosurgery and Stereotactic Brain Radiotherapy with Systemic Therapy in Recurrent High-Grade Gliomas: Is It Feasible? Therapeutic Strategies in Recurrent High-Grade Gliomas.
Gregucci F; Surgo A; Carbonara R; Laera L; Ciliberti MP; Gentile MA; Caliandro M; Sasso N; Bonaparte I; Fanelli V; Tortora R; Paulicelli E; Surico G; Lombardi G; Signorelli F; Fiorentino A
J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013284
[TBL] [Abstract][Full Text] [Related]
59. Effectiveness of proton beam therapy for liver oligometastatic recurrence in patients with postoperative esophagus cancer.
Yamaguchi H; Kato T; Honda M; Hamada K; Seto I; Tominaga T; Takagawa Y; Takayama K; Suzuki M; Kikuchi Y; Teranishi Y; Murakami M
J Radiat Res; 2023 May; 64(3):582-589. PubMed ID: 36913708
[TBL] [Abstract][Full Text] [Related]
60. [Proton beam therapy with concurrent chemotherapy for non-small cell lung cancer -- our experiences and future direction].
Niho S; Motegi A; Akimoto T
Gan To Kagaku Ryoho; 2015 Feb; 42(2):144-7. PubMed ID: 25743132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
